HealthApr 2, 2026FDA approves Foundayo (orforglipron), a once-daily oral GLP-1 weight-loss pill developed by Eli LillyThe U.S. Food and Drug Administration approved Foundayo (orforglipron), an oral once-daily GLP-1 medication developed by Eli Lilly for chronic weight management in a...Foundayo (orforglipron)GLP-1 drugsFDA
